HYDERABAD, India — Dr. Reddy's Labs announced the launch of valganciclovir tablets USP in 450-mg strength. The drug is the generic version of Valcyte tabs from Hoffmann-La Roche Inc.
Valcyte tabs had sales in the United States of $440 million for the 12 months ending October 2014, according to IMS Health data. Dr. Reddy's valganciclovir tablets, USP is available in bottle counts of 60.